HUP9800521A3 - Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or propylaxis of hyperlipoproteinaemia, hypertriglyceridaemia, hyperlipidaemia or hypercholesterolaemia or arteriosclerosis - Google Patents
Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or propylaxis of hyperlipoproteinaemia, hypertriglyceridaemia, hyperlipidaemia or hypercholesterolaemia or arteriosclerosisInfo
- Publication number
- HUP9800521A3 HUP9800521A3 HU9800521A HUP9800521A HUP9800521A3 HU P9800521 A3 HUP9800521 A3 HU P9800521A3 HU 9800521 A HU9800521 A HU 9800521A HU P9800521 A HUP9800521 A HU P9800521A HU P9800521 A3 HUP9800521 A3 HU P9800521A3
- Authority
- HU
- Hungary
- Prior art keywords
- propylaxis
- hyperlipoproteinaemia
- hypertriglyceridaemia
- hypercholesterolaemia
- hyperlipidaemia
- Prior art date
Links
- 208000031226 Hyperlipidaemia Diseases 0.000 title 2
- 206010003210 Arteriosclerosis Diseases 0.000 title 1
- 208000035150 Hypercholesterolemia Diseases 0.000 title 1
- 208000011775 arteriosclerosis disease Diseases 0.000 title 1
- 239000004305 biphenyl Substances 0.000 title 1
- 208000006575 hypertriglyceridemia Diseases 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK4195 | 1995-01-13 | ||
| DK4395 | 1995-01-13 | ||
| DK6995 | 1995-01-20 | ||
| DK76695 | 1995-06-30 | ||
| DK76795 | 1995-06-30 | ||
| DK77795 | 1995-06-30 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP9800521A2 HUP9800521A2 (en) | 1998-12-28 |
| HUP9800521A3 true HUP9800521A3 (en) | 1999-12-28 |
Family
ID=27545138
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9800521A HUP9800521A3 (en) | 1995-01-13 | 1996-01-10 | Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or propylaxis of hyperlipoproteinaemia, hypertriglyceridaemia, hyperlipidaemia or hypercholesterolaemia or arteriosclerosis |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0804189A1 (en) |
| JP (1) | JPH10511961A (en) |
| CN (1) | CN1168098A (en) |
| AU (1) | AU4329296A (en) |
| BR (1) | BR9606890A (en) |
| CA (1) | CA2208859A1 (en) |
| CZ (1) | CZ212397A3 (en) |
| HU (1) | HUP9800521A3 (en) |
| IL (1) | IL116745A (en) |
| NO (1) | NO973241D0 (en) |
| WO (1) | WO1996021443A1 (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5407955A (en) * | 1994-02-18 | 1995-04-18 | Eli Lilly And Company | Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease |
| US6069175A (en) * | 1996-11-15 | 2000-05-30 | Pfizer Inc. | Estrogen agonist/antagonists treatment of atherosclerosis |
| WO1999048497A1 (en) * | 1998-03-20 | 1999-09-30 | Novo Nordisk A/S | USE OF 3,4-DIPHENYLCHROMANS FOR THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION FOR LOWERING PLASMA LEVELS OF Lp(a) IN A HUMAN OR SUB-HUMAN PRIMATE |
| US7005428B1 (en) | 1998-06-11 | 2006-02-28 | Endorecherche, Inc. | Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| US6465445B1 (en) * | 1998-06-11 | 2002-10-15 | Endorecherche, Inc. | Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| EP1794141B1 (en) | 2004-09-21 | 2011-11-09 | Marshall Edwards, Inc. | Substituted chroman derivatives, medicaments and use in therapy |
| US8080675B2 (en) | 2004-09-21 | 2011-12-20 | Marshall Edwards, Inc. | Chroman derivatives, medicaments and use in therapy |
| US9663484B2 (en) | 2010-11-01 | 2017-05-30 | Mei Pharma, Inc. | Isoflavonoid compounds and methods for the treatment of cancer |
| CN108484559A (en) | 2014-02-07 | 2018-09-04 | 凯捷治疗有限公司 | Functionalized benzopyran compounds and application thereof |
| CN116139125A (en) | 2015-02-02 | 2023-05-23 | 梅制药公司 | Combination therapy |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1543749A1 (en) * | 1966-02-16 | 1969-12-11 | Merck Ag E | Process for the preparation of 3,4-cis-4-aryl-isoflavans |
| US5407955A (en) * | 1994-02-18 | 1995-04-18 | Eli Lilly And Company | Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease |
-
1996
- 1996-01-10 CA CA002208859A patent/CA2208859A1/en not_active Abandoned
- 1996-01-10 AU AU43292/96A patent/AU4329296A/en not_active Abandoned
- 1996-01-10 WO PCT/DK1996/000014 patent/WO1996021443A1/en not_active Application Discontinuation
- 1996-01-10 EP EP96900095A patent/EP0804189A1/en not_active Withdrawn
- 1996-01-10 CZ CZ972123A patent/CZ212397A3/en unknown
- 1996-01-10 HU HU9800521A patent/HUP9800521A3/en unknown
- 1996-01-10 JP JP8521377A patent/JPH10511961A/en active Pending
- 1996-01-10 BR BR9606890A patent/BR9606890A/en not_active Application Discontinuation
- 1996-01-10 CN CN96191417A patent/CN1168098A/en active Pending
- 1996-01-12 IL IL11674596A patent/IL116745A/en not_active IP Right Cessation
-
1997
- 1997-07-11 NO NO973241A patent/NO973241D0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL116745A (en) | 1999-12-22 |
| WO1996021443A1 (en) | 1996-07-18 |
| IL116745A0 (en) | 1996-05-14 |
| HUP9800521A2 (en) | 1998-12-28 |
| CZ212397A3 (en) | 1997-11-12 |
| NO973241L (en) | 1997-07-11 |
| CN1168098A (en) | 1997-12-17 |
| CA2208859A1 (en) | 1996-07-18 |
| JPH10511961A (en) | 1998-11-17 |
| AU4329296A (en) | 1996-07-31 |
| BR9606890A (en) | 1997-10-28 |
| NO973241D0 (en) | 1997-07-11 |
| EP0804189A1 (en) | 1997-11-05 |
| MX9705214A (en) | 1997-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1008180A1 (en) | Use of vitamin d 2 or vitamin d 4-derivatives for the manufacture of a medicament for the treatment of secondary hyperparathyroidism | |
| CA2218714A1 (en) | Dosage form comprising oxybutynin | |
| CA2194167A1 (en) | Hair-growing agent | |
| ZA962854B (en) | Emulsion suitable for administering a poorly water-soluble photosensitizing compound and use thereof | |
| ZA965368B (en) | A pharmaceutical formulation | |
| AU6552398A (en) | Testing the effectiveness of a sterilization procedure | |
| EP0740937A3 (en) | Use of retinoids for the manufacture of a pharmaceutical or cosmetic composition | |
| ZA96124B (en) | A pharmaceutical formulation | |
| AU6001496A (en) | A rinse-off cosmetic cleansing composition | |
| IL116746A0 (en) | Use of 3, 4-diphenyl chromans for the preparation of pharmaceutical compositions | |
| HUP9800521A3 (en) | Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or propylaxis of hyperlipoproteinaemia, hypertriglyceridaemia, hyperlipidaemia or hypercholesterolaemia or arteriosclerosis | |
| ZA958606B (en) | A pharmaceutical formulation | |
| AU7630296A (en) | Compositions for the treatment of keratinic materials containing the association of a polyampholyte polymer and cationic polymer | |
| IL116828A0 (en) | Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions | |
| FR2736826B1 (en) | FILTERING COMPOSITION FOR COSMETIC OR DERMATOLOGICAL USE | |
| IL117629A0 (en) | Pharmaceutical compositions containing a benzamide derivative and methods for the preparation thereof | |
| IL116826A0 (en) | Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions | |
| ZA96251B (en) | Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of hyperlipoproteinaemia, hypertriglyceridaemia, hyperlipidaemia or hypercholesterolaemia or arteriosclerosis or for anticoagulative treatment. | |
| ZA98681B (en) | Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for inhibition senescense-associated motor impairment | |
| ZA964372B (en) | A pharmaceutical formulation | |
| IL116827A0 (en) | Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions | |
| IL116747A0 (en) | Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions | |
| ZA965367B (en) | A pharmaceutical formulation | |
| AU5515196A (en) | Laryngeal bactericidal and antiseptic composition | |
| AU3433997A (en) | Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for lowering intraocular pressure |